Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

• Asıl Yazarlar: Saowalak Turongkaravee (Yazar), Jiraphun Jittikoon (Yazar), Onwipa Rochanathimoke (Yazar), Kathleen Boyd (Yazar), Olivia Wu (Yazar), Usa Chaikledkaew (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2021-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Genetic testing has potential roles in identifying whether an individual would have risk of adverse drug reactions (ADRs) from a particular medicine. Robust cost-effectiveness results on genetic testing would be useful for clinical practice and policy decision-making on allocatin...